BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7595054)

  • 1. Function of the urokinase receptor (CD87) in neutrophil chemotaxis.
    Gyetko MR; Sitrin RG; Fuller JA; Todd RF; Petty H; Standiford TJ
    J Leukoc Biol; 1995 Nov; 58(5):533-8. PubMed ID: 7595054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
    Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
    J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urokinase receptor is required for human monocyte chemotaxis in vitro.
    Gyetko MR; Todd RF; Wilkinson CC; Sitrin RG
    J Clin Invest; 1994 Apr; 93(4):1380-7. PubMed ID: 8163642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.
    Sitrin RG; Todd RF; Albrecht E; Gyetko MR
    J Clin Invest; 1996 Apr; 97(8):1942-51. PubMed ID: 8621779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.
    Gyetko MR; Sud S; Kendall T; Fuller JA; Newstead MW; Standiford TJ
    J Immunol; 2000 Aug; 165(3):1513-9. PubMed ID: 10903758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils.
    Sitrin RG; Pan PM; Harper HA; Todd RF; Harsh DM; Blackwood RA
    J Immunol; 2000 Sep; 165(6):3341-9. PubMed ID: 10975852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
    Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
    EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.
    Gyetko MR; Aizenberg D; Mayo-Bond L
    J Leukoc Biol; 2004 Sep; 76(3):648-56. PubMed ID: 15240745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells.
    Lanza F; Castoldi GL; Castagnari B; Todd RF; Moretti S; Spisani S; Latorraca A; Focarile E; Roberti MG; Traniello S
    Br J Haematol; 1998 Oct; 103(1):110-23. PubMed ID: 9792297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased neutrophil motility by beta-glucan in the absence of chemoattractant.
    Harler MB; Reichner J
    Shock; 2001 Dec; 16(6):419-24. PubMed ID: 11770038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urokinase receptor. A cell surface, regulated chemokine.
    Blasi F
    APMIS; 1999 Jan; 107(1):96-101. PubMed ID: 10190285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
    Bohuslav J; Horejsí V; Hansmann C; Stöckl J; Weidle UH; Majdic O; Bartke I; Knapp W; Stockinger H
    J Exp Med; 1995 Apr; 181(4):1381-90. PubMed ID: 7535337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
    Xue W; Kindzelskii AL; Todd RF; Petty HR
    J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
    Pliyev BK; Antonova OA; Menshikov M
    Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
    de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
    J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes.
    Sitrin RG; Pan PM; Harper HA; Blackwood RA; Todd RF
    J Immunol; 1999 Dec; 163(11):6193-200. PubMed ID: 10570311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration.
    Leksa V; Godár S; Cebecauer M; Hilgert I; Breuss J; Weidle UH; Horejsí V; Binder BR; Stockinger H
    J Biol Chem; 2002 Oct; 277(43):40575-82. PubMed ID: 12189157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils.
    Sitrin RG; Pan PM; Blackwood RA; Huang J; Petty HR
    J Immunol; 2001 Apr; 166(8):4822-5. PubMed ID: 11290756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
    Kindzelskii AL; Laska ZO; Todd RF; Petty HR
    J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.